Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients
Late Cardiac Evaluation of the Three Arm Belgian Trial A Phase III Randomized Trial Involving Node-positive Early Breast Cancer Patients With a Long Median Follow-up (~ 15 Years)
Sponsor: Centre Hospitalier Jolimont-Lobbes
A PHASE2 clinical study on Breast Cancer, this trial is completed. The trial is conducted by Centre Hospitalier Jolimont-Lobbes and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Dec 2019 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Jolimont-Lobbes
- Centre Hospitalier Universitaire de Tivoli
- Clinique Sainte Elisabeth
- Hôpital de Braine-l'Alleud
- Jules Bordet Institute
- Réseau Hospitalier Médecine Sociale d'Ath
For direct contact, visit the study record on ClinicalTrials.gov .